Thomas Gruenberger Selected Research

Irinotecan (Camptosar)

1/2013	Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.
1/2010	Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
10/2008	Urgent need for a new staging system in advanced colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Gruenberger Research Topics

Disease

33	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2002
23	Neoplasms (Cancer) 04/2024 - 03/2002
19	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 03/2002
11	Liver Diseases (Liver Disease) 01/2024 - 07/2014
6	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 10/2007
5	Fibrosis (Cirrhosis) 08/2023 - 02/2010
2	Carcinogenesis 04/2024 - 01/2009
2	Cholangiocarcinoma 01/2024 - 01/2023
2	Liver Failure 11/2023 - 12/2013
2	Portal Hypertension 08/2023 - 01/2023
2	Neutropenia 01/2023 - 08/2020
2	Leukopenia 01/2023 - 12/2022
2	Diarrhea 01/2023 - 08/2020
2	Hemorrhage 12/2022 - 04/2008
2	Inflammation (Inflammations) 01/2022 - 11/2005
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2010 - 06/2009
1	End Stage Liver Disease 08/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023
1	Microsatellite Instability 01/2023
1	Chemical and Drug Induced Liver Injury 01/2023
1	Stroke (Strokes) 01/2023
1	Exanthema (Rash) 01/2023
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2023
1	Hypersplenism (Anemia, Splenic) 12/2022
1	Thrombocytopenia (Thrombopenia) 12/2022
1	Anemia 12/2022
1	Cytopenia 12/2022
1	Hyperplasia 12/2022
1	Febrile Neutropenia 08/2020
1	Adenoma (Adenomas) 07/2017
1	Lymphatic Metastasis 02/2012
1	Wounds and Injuries (Trauma) 06/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2011
1	Non-alcoholic Fatty Liver Disease 02/2011
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2011

Drug/Important Bio-Agent (IBA)

11	Bevacizumab (Avastin)FDA Link 02/2024 - 04/2008
7	Biomarkers (Surrogate Marker)IBA 08/2023 - 07/2014
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013 - 04/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023 - 04/2008
3	XELOXIBA 02/2024 - 04/2008
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 10/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2024 - 08/2023
2	AlbuminsIBA 08/2023 - 01/2023
2	Gemcitabine FDA Link 01/2023 - 12/2010
2	BilirubinIBA 01/2023 - 12/2013
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2016 - 06/2011
2	Leucovorin (Folinic Acid)FDA Link 11/2013 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 11/2013 - 01/2010
2	Carcinoembryonic AntigenIBA 09/2012 - 03/2002
2	Cetuximab (Erbitux)FDA Link 12/2010 - 01/2010
2	TOR Serine-Threonine KinasesIBA 06/2009 - 08/2007
2	Monoclonal AntibodiesIBA 10/2008 - 04/2008
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2024
1	ChemokinesIBA 04/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2024
1	Deoxyribonuclease I (Nickase)IBA 01/2024
1	4-(3-chlorophenylsulfanyl)piperidineIBA 08/2023
1	LigandsIBA 08/2023
1	Fetal Proteins (Fetoprotein)IBA 08/2023
1	AntibodiesIBA 05/2023
1	Panitumumab (Vectibix)FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2021
1	von Willebrand FactorIBA 11/2018
1	Genetic Markers (Genetic Marker)IBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	AntigensIBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 12/2017
1	clonidine-displacing substance (ClDS)IBA 07/2017
1	Antithrombin IIIIBA 01/2017
1	Messenger RNA (mRNA)IBA 11/2016
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	P-SelectinIBA 05/2016
1	Thrombospondin 1IBA 05/2016
1	AngiopoietinsIBA 06/2015
1	Thrombopoietin (c-mpl Ligand)IBA 01/2015
1	gadolinium ethoxybenzyl DTPA FDA Link 12/2013
1	CytokinesIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2011
1	Alkaline PhosphataseIBA 02/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2010
1	Mitogen-Activated Protein KinasesIBA 06/2009
1	ErbB Receptors (EGF Receptor)IBA 06/2009
1	Sirolimus (Rapamycin)FDA Link 06/2009
1	Isoflurane FDA LinkGeneric 02/2009
1	Nitrous Oxide (Laughing Gas)IBA 02/2009

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 02/2024 - 03/2002
15	Therapeutics 02/2024 - 06/2003
15	Neoadjuvant Therapy 01/2024 - 04/2008
3	Hepatectomy 11/2023 - 01/2015
3	Contraindications 12/2022 - 02/2012
3	Adjuvant Chemotherapy 08/2016 - 02/2005
2	Minimally Invasive Surgical Procedures 11/2023 - 01/2023
1	Induction Chemotherapy 05/2023
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022
1	Transjugular Intrahepatic Portasystemic Shunt 12/2022